HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Guo-Wei He Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wei, W. Articles by He, G.-W. Search for Related Content PubMed PubMed Citation Articles by Wei, W. Articles by He, G.-W. Related Collections Coronary disease

Ann Thorac Surg 2002;73:516-522
© 2002 The Society of Thoracic Surgeons

---

Original article: cardiovascular

Interaction between vasodilators and vasopressin in internal mammary artery and clinical significance

^a Cardiovascular Research, Starr Academic Center, Providence Heart Institute, Department of Surgery, Oregon Health Sciences University, Portland, Oregon, USA
^b Division of Cardiothoracic Surgery, Department of Surgery, The Chinese University of Hong Kong, Hong Kong SAR, China

Accepted for publication September 19, 2001.

* Address reprint requests to Dr He, Department of Surgery, The Chinese University of Hong Kong, Block B, 5A, Prince of Wales Hospital, Shatin, N.T., Hong Kong SAR, China
e-mail: gwhe{at}cuhk.edu.hk

Background. Arginine vasopressin (AVP) has recently been demonstrated as an alternative in the treatment of severe refractory vasodilatation in coronary artery bypass grafting. However, AVP may be a spasmogen for graft spasm. We compared the in vitro antispastic effect among calcium-channel antagonists (nifedipine, diltiazem, and verapamil), nitroglycerin, and the highly selective AVP (V1) receptor antagonist [1-deaminopenicillamine, 4-valine, 8-D-arginine] vasopressin.

Methods. Human internal mammary artery segments (n = 218) were studied in organ baths. The inhibitory effects of the above vasodilators on AVP-mediated contraction were studied in two ways: relaxation with AVP precontraction and depression of the AVP-induced contraction after pretreatment with vasodilators.

Results. All three calcium-channel antagonists caused limited relaxation (18.3% ± 5.4% for nifedipine, n = 11; 22.2% ± 3.8% for verapamil, n = 10; and 26.2% ± 7.5% for diltiazem, n = 9). The plasma concentration of calcium-channel antagonists had no significant depression effect on the AVP-induced contraction. In contrast, [1-deaminopenicillamine, 4-valine, 8-D-arginine] vasopressin caused full (100%, n = 11) and nitroglycerin caused nearly full (93% ± 3%, n = 10) relaxation. Pretreatment with [1-deaminopenicillamine, 4-valine, 8-D-arginine] vasopressin (10^-8, 10^-7, or 10^-6 mol/L, respectively) significantly increased the effective concentration for 50% of the AVP-induced contraction (10^-8.6 ± 10^0.1 mol/L, p = 0.009; 10^-7.8 ± 10^0.07 mol/L, p = 0.000; or 10^-6.9 ± 10^0.11 mol/L, p = 0.000 versus the control, 10^-9.24 ± 10^0.16 mol/L). However, nitroglycerin only slightly depressed the AVP-induced contraction.

Conclusions. [1-Deaminopenicillamine, 4-valine, 8-D-arginine] vasopressin may provide specific antispastic effect in either prophylaxis or treatment of the AVP-related vasospasm in the internal mammary artery. Nitroglycerin may be effective in treatment but has little effect on prophylaxis. Use of calcium-channel antagonists may have little benefit in AVP-related vasospasm.

This article has been cited by other articles:

				G.-W. He, L. Fan, A. Furnary, and Q. Yang A new antispastic solution for arterial grafting: Nicardipine and nitroglycerin cocktail in preparation of internal thoracic and radial arteries for coronary surgery J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 673 - 680. [Abstract] [Full Text] [PDF]

				S. Novella, A. C. Martinez, R. M. Pagan, M. Hernandez, A. Garcia-Sacristan, A. Gonzalez-Pinto, J. M. Gonzalez-Santos, and S. Benedito Plasma levels and vascular effects of vasopressin in patients undergoing coronary artery bypass grafting Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 69 - 76. [Abstract] [Full Text] [PDF]

				O. A. Khan, C. Torrens, D. E. Noakes, L. Poston, M. A. Hanson, L. R. Green, and S. K. Ohri Effects of pre-natal and early post-natal undernutrition on adult internal thoracic artery function Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 811 - 815. [Abstract] [Full Text] [PDF]

				W. Wei, C.-Q. Yang, A. Furnary, and G.-W. He Greater vasopressin-induced vasoconstriction and inferior effects of nitrovasodilators and milrinone in the radial artery than in the internal thoracic artery J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 33 - 40. [Abstract] [Full Text] [PDF]

				Y. Tabel, H. Hepaguslar, C. Erdal, H. Catalyurek, U. Acikel, Z. Elar, and O. Aslan Diltiazem provides higher internal mammary artery flow than nitroglycerin during coronary artery bypass grafting surgery Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 553 - 559. [Abstract] [Full Text] [PDF]

				A. R. Conant, M. J. Shackcloth, A. Y. Oo, M. R. Chester, A. W. M. Simpson, and W. C. Dihmis Phenoxybenzamine treatment is insufficient to prevent spasm in the radial artery: the effect of other vasodilators J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 448 - 454. [Abstract] [Full Text] [PDF]